Tag
Anuh Pharma Limited
2 articles
Anuh Pharma Q1 PAT Jumps 37.6% to ₹11.42 Crore
Anuh Pharma reported Q1 FY27 PAT of ₹11.42 Cr, up 37.63% YoY, driven by a richer product mix and cost control.
EBITDA grew 41.56% YoY to ₹19.36 Cr, with ROCE improving 326 bps to 19.18% on higher prof
Anuh Pharma Promoters Withdraw Reclassification Request
Anuh Pharma Ltd discloses withdrawal of application to reclassify three promoter group members from 'Promoter' to 'Public' category.
Vikram Kirtilal Shah, Kiran Piyush Shah, and Kinjal Siddharth Jhave